Global Health declared a final dividend of ₹0.50 per equity share for FY26 during its 22nd Annual General Meeting held on September 16, 2026. The meeting, conducted via video conferencing, also saw the re-election of Group CEO Pankaj Sahni as a director.

The company adopted its audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. The auditors’ report contained no qualifications, observations, or comments on the financial statements or the secretarial audit report.

Key Resolutions Passed

Shareholders approved the following ordinary resolutions:

• Adoption of audited standalone and consolidated financial statements for FY26.
• Declaration of final dividend of ₹0.50 per equity share.
• Re-election of Mr. Pankaj Sahni (DIN: 07132999) as a director upon retirement by rotation.
• Approval of remuneration for M/s Ramanath Iyer & Co. as cost auditors for FY27.

Management Commentary

Dr. Naresh Trehan, Chairman & Managing Director, opened the meeting by thanking shareholders for their continued support. He highlighted the company’s commitment to excellence in healthcare delivery and patient care.

Mr. Pankaj Sahni, Group CEO & Director, updated members on the key financial and operational achievements for FY26. He acknowledged the guidance provided by the Board of Directors and the support from all stakeholders.

Meeting Details

The quorum was present at the start of the meeting. Remote e-voting was available from September 12, 2026, to September 15, 2026. M/s Mukesh Agarwal & Co., Company Secretaries, served as the scrutinizer for the voting process. Consolidated voting results were scheduled for dissemination to stock exchanges and publication on the company website by September 18, 2026.

Global Health has scheduled group meetings with analysts and investors on September 17 and 18, 2026. The engagements are part of larger industry forums organized by Jefferies and Kotak.

Meeting details

The company’s management will participate in two separate group sessions across two consecutive days. These meetings serve as a platform for direct engagement with market participants. No unpublished price-sensitive information is proposed to be shared during these interactions.

Schedule specifics

The first session is scheduled for September 17, 2026, as part of the Jefferies India Forum 2026. This meeting will be held in person in Gurugram. The second session follows on September 18, 2026, under the Kotak Healthcare Forum 2026 banner, taking place in person in Mumbai.

Global Health Limited confirmed these details pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule remains subject to change in case of unforeseen circumstances.